Business

Global View: Siemens, Dr Reddy’s Laboratories, Honeywell Automation May Bring 17-27% Profit

The Indian market, which closed at a rise of about 1% in the week ending December 3, could consolidate on Monday amid the calm trends seen in the Asian market.

See ZeeBusiness Live TV Streaming below.

According to a Zee Business TV report, we have compiled a list of recommendations from various global brokerage firms.

Siemens: Buy

Jeffreys maintained the Siemens purchase rating, but lowered the target price from the previous 2670 rupees to 2,560 rupees. The target price reduction will translate from a record of 2185 rupees on December 3rd to an increase of more than 17%.

Management is optimistic about the business. At the center, infrastructure spending in the central government sector may increase and the private sector may increase.

The scale up of state spending is gradual. The company will benefit from margin traction as revenues increase as decarbonization progresses.

Global investment banks will reduce their earnings per share (EPS) by 2-4% in 2010-23, taking into account the impact of commodity / logistics costs on margins.

Doctor Reddies Laboratories: Buy

Nomura maintained the Dr. Reddy’s Laboratories buy rating at a target price of Rs 5856. This corresponds to an increase of more than 27% from the 4598 rupees recorded on December 3rd.

None of the observations at the Duvvada facility are classified as repetitive observations, and some observations are procedural in nature.

As a base case, Global Investment Banking expects pharmaceutical companies to undertake a satisfactory observation of the US Food and Drug Administration (FDA).

There are no signs of a significant lack of control over the current process

Honeywell Automation India Ltd: Purchase

Nomura maintained the purchase rating of Honeywell Automation India Ltd, but lowered the target price from the previous 53,750 rupees to 47,792 rupees. The reduction in the target price will lead to an increase of more than 23% from the 38,633 rupees recorded on December 3.

Global Investment Banks will reduce FY23 / 24 EPS by 15% to account for extended lead times. According to notes, the long-term outlook remains solid as digital spending increases.

The slowdown in private capital investment and the demand for exports from the parent company are important risks. In addition, potential commodity price increases and the resulting margin pressure are other important risks investors should be aware of.

(Disclaimer: The views / suggestions / advice presented here in this article are by investment experts only. ZeeBusiness advises readers to consult an investment adviser before making financial decisions. It is recommended.)



Global View: Siemens, Dr Reddy's Laboratories, Honeywell Automation May Bring 17-27% Profit

Source link Global View: Siemens, Dr Reddy's Laboratories, Honeywell Automation May Bring 17-27% Profit

Related Articles

Back to top button